...
首页> 外文期刊>Journal of clinical virology: The official publication of the Pan American Society for Clinical Virology >Contribution of human herpesvirus 6 (HHV-6) viral load in whole blood and serum to investigate integrated HHV-6 transmission after haematopoietic stem cell transplantation.
【24h】

Contribution of human herpesvirus 6 (HHV-6) viral load in whole blood and serum to investigate integrated HHV-6 transmission after haematopoietic stem cell transplantation.

机译:人类疱疹病毒6(HHV-6)在全血和血清中的病毒载量对造血干细胞移植后HHV-6整合传播的研究。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Human herpesvirus 6 (HHV-6) is susceptible to latency and recurrence. A less-frequent form of HHV-6 persistence is the integration of viral DNA into host chromosomes. OBJECTIVES: To investigate HHV-6 viral load after haematopoietic stem cell transplantation (HSCT) in whole blood (WB) and serum with regard to integrated HHV-6 transmission diagnosis. STUDY DESIGN: HHV-6 DNA quantitation in serum and WB was performed using quantitative polymerase chain reaction for the follow-up of a 16-year-old girl after HSCT. In whole blood, results were expressed as HHV-6 genomic equivalent copies (gec) per milliliter of WB or per million cells. RESULTS: HHV-6 viral load (undetectable before HSCT) increased up to 3.05 x 10(7)gec/10(6)cells. HHV-6 viral load in the donor sample (3.44 x 10(6)gec/10(6)cells) was in favor of viral transmission through HSCT. The correlation between viral load in WB and serum was significant (p=0.0005). Viral load results expressed as gec/10(6)cells in WB was more reliable than results expressed as gec/ml of whole blood. CONCLUSION: These findings indicate that HHV-6 may be transmitted during HSCT as integrated virus contained in the graft. This reiterates that in the setting of HSCT, HHV-6 viral load must be correctly interpreted. Using HHV-6 viral load expressed as gec/10(6) cells may be more suitable for the follow-up of patients with integrated HHV-6.
机译:背景:人类疱疹病毒6(HHV-6)容易出现潜伏期和复发。 HHV-6持久性的一种较不常见的形式是将病毒DNA整合到宿主染色体中。目的:研究全血(WB)和血清中造血干细胞移植(HSCT)后的HHV-6病毒载量,以进行综合的HHV-6传播诊断。研究设计:血清和WB中的HHV-6 DNA定量使用定量聚合酶链反应进行,用于HSCT后16岁女孩的随访。在全血中,结果表示为每毫升WB或每百万个细胞HHV-6基因组当量拷贝(gec)。结果:HHV-6病毒载量(HSCT之前无法检测)增加至3.05 x 10(7)gec / 10(6)个细胞。供体样品(3.44 x 10(6)gec / 10(6)个细胞)中的HHV-6病毒载量有利于通过HSCT进行病毒传播。 WB中病毒载量与血清之间的相关性显着(p = 0.0005)。 WB中以gec / 10(6)细胞表示的病毒载量结果比以gec / ml全血表示的结果更可靠。结论:这些发现表明,HHV-6可能在HSCT期间作为移植物中所含的整合病毒传播。重申在HSCT的设置中,必须正确解释HHV-6病毒载量。使用表达为gec / 10(6)细胞的HHV-6病毒载量可能更适合合并HHV-6的患者的随访。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号